{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:54:36Z","timestamp":1781679276937,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05101-x","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:56:12Z","timestamp":1780592172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of changes in glomerular lesions in children diagnosed with IgA nephropathy following immunosuppressive therapy"],"prefix":"10.1186","volume":"27","author":[{"given":"Jia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao-hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan-li","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao-jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-qian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-juan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"issue":"25","key":"5101_CR1","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1056\/NEJMra1206793","volume":"368","author":"RJ Wyatt","year":"2013","unstructured":"Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013;368(25):2402\u201314. https:\/\/doi.org\/10.1056\/NEJMra1206793.","journal-title":"N Engl J Med"},{"issue":"5","key":"5101_CR2","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/ki.2015.252","volume":"88","author":"R Magistroni","year":"2015","unstructured":"Magistroni R, D\u2019Agati VD, Appel GB, Kiryluk K. New developments in the genetics, pathogenesis, and therapy of IgA nephropathy. Kidney Int. 2015;88(5):974\u201389. https:\/\/doi.org\/10.1038\/ki.2015.252.","journal-title":"Kidney Int"},{"issue":"3","key":"5101_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1053\/j.ajkd.2021.01.024","volume":"78","author":"P Pattrapornpisut","year":"2021","unstructured":"Pattrapornpisut P, Avila-Casado C, Reich HN. IgA Nephropathy: Core Curriculum 2021[J]. Am J Kidney Dis. 2021;78(3):429\u201341. https:\/\/doi.org\/10.1053\/j.ajkd.2021.01.024.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"5101_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2215\/CJN.0000000000000135","volume":"18","author":"D Pitcher","year":"2023","unstructured":"Pitcher D, Braddon F, Hendry B, Mercer A, Osmaston K, Saleem MA, et al. Long-term Outcomes in IgA Nephropathy. CJASN. 2023;18(6):727\u201338. https:\/\/doi.org\/10.2215\/CJN.0000000000000135.","journal-title":"CJASN"},{"issue":"8","key":"5101_CR5","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s00467-024-06361-1","volume":"39","author":"B Su","year":"2024","unstructured":"Su B, Jiang Y, Li Z, Zhou J, Rong L, Feng S, et al. Are children with IgA nephropathy different from adult patients? Pediatr Nephrol. 2024;39(8):2403\u201312. https:\/\/doi.org\/10.1007\/s00467-024-06361-1.","journal-title":"Pediatr Nephrol"},{"key":"5101_CR6","doi-asserted-by":"publisher","unstructured":"National Research Group on the Diagnosis and Treatment Status of Common Kidney Diseases in Children. A multicenter retrospective study on the current treatment status of IgA nephropathy in Chinese children [J]. Chin J Pediatr. 2013;51(7):486\u201390. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1310.2013.07.003.","DOI":"10.3760\/cma.j.issn.0578-1310.2013.07.003"},{"issue":"6","key":"5101_CR7","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s40620-020-00767-4","volume":"33","author":"H Wu","year":"2020","unstructured":"Wu H, Fang X, Xia Z, Gao C, Peng Y, Li X, et al. Long-term renal survival and undetected risk factors of IgA nephropathy in Chinese children\u2014a retrospective 1243 cases analysis from single centre experience. J Nephrol. 2020;33(6):1263\u201373. https:\/\/doi.org\/10.1007\/s40620-020-00767-4.","journal-title":"J Nephrol"},{"issue":"23","key":"5101_CR8","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1056\/NEJMoa1415463","volume":"373","author":"T Rauen","year":"2015","unstructured":"Rauen T, Eitner F, Fitzner C, Sommerer C, Zeier M, Otte B, et al. Intensive supportive care plus immunosuppression in IgA Nephropathy. N Engl J Med. 2015;373(23):2225\u201336. https:\/\/doi.org\/10.1056\/NEJMoa1415463.","journal-title":"N Engl J Med"},{"issue":"4","key":"5101_CR9","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.kint.2020.04.046","volume":"98","author":"T Rauen","year":"2020","unstructured":"Rauen T, Wied S, Fitzner C, Eitner F, Sommerer C, Zeier M, et al. After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy. Kidney Int. 2020;98(4):1044\u201352. https:\/\/doi.org\/10.1016\/j.kint.2020.04.046.","journal-title":"Kidney Int"},{"key":"5101_CR10","doi-asserted-by":"publisher","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) IgAN and IgAV Work Group, Rovin BH, Barratt J, et al. KDIGO 2025 clinical Practice Guideline for the Management of Immunoglobulin a nephropathy (IgAN) and Immunoglobulin a Vasculitis (IgAV). Kidney Int. 2025;108(4):S1\u201371. https:\/\/doi.org\/10.1016\/j.kint.2025.04.004.","DOI":"10.1016\/j.kint.2025.04.004"},{"issue":"6","key":"5101_CR11","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1053\/j.ackd.2017.09.011","volume":"24","author":"AN Mian","year":"2017","unstructured":"Mian AN, Schwartz GJ. Measurement and estimation of glomerular filtration rate in Children. Adv Chronic Kidney Dis. 2017;24(6):348\u201356. https:\/\/doi.org\/10.1053\/j.ackd.2017.09.011.","journal-title":"Adv Chronic Kidney Dis"},{"key":"5101_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jpeds.2021.04.011","volume":"235","author":"BS Zemel","year":"2021","unstructured":"Zemel BS. The challenges of interpreting body Mass index in children with Obesity. J Sport Hist Pediatrics. 2021;235:21\u201322. https:\/\/doi.org\/10.1016\/j.jpeds.2021.04.011.","journal-title":"J Sport Hist Pediatrics"},{"issue":"5","key":"5101_CR13","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","volume":"91","author":"H Trimarchi","year":"2017","unstructured":"Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, et al. Oxford classification of IgA nephropathy 2016: an update from the IgA nephropathy classification Working Group. Kidney Int. 2017;91(5):1014\u201321. https:\/\/doi.org\/10.1016\/j.kint.2017.02.003.","journal-title":"Kidney Int"},{"issue":"5","key":"5101_CR14","first-page":"428","volume":"25","author":"H Fan","year":"2017","unstructured":"Fan H, Yan YK, Mi J. Reference standards for blood pressure by sex, age, and height in Chinese children aged 3\u201317 years. Chin J Hypertens. 2017;25(5):428\u201335.","journal-title":"Chin J Hypertens"},{"issue":"2","key":"5101_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00467-024-06502-6","volume":"40","author":"M Vivarelli","year":"2025","unstructured":"Vivarelli M, Samuel S, Coppo R, Barratt J, Bonilla-Felix M, Haffner D, et al. IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis. Pediatr Nephrol. 2025;40(2):533\u201369. https:\/\/doi.org\/10.1007\/s00467-024-06502-6.","journal-title":"Pediatr Nephrol"},{"issue":"28","key":"5101_CR16","doi-asserted-by":"publisher","first-page":"46436","DOI":"10.18632\/oncotarget.17502","volume":"8","author":"X Shao","year":"2017","unstructured":"Shao X, Li B, Cao L, Liang L, Yang J, Wang Y, et al. Evaluation of crescent formation as a predictive marker in immunoglobulin a nephropathy: a systematic review and meta-analysis. Oncotarget. 2017;8(28):46436\u201348. https:\/\/doi.org\/10.18632\/oncotarget.17502.","journal-title":"Oncotarget"},{"issue":"159","key":"5101_CR17","first-page":"19","volume":"30","author":"MN Luo","year":"2020","unstructured":"Luo MN, Pan Q, Huang ZQ, Li SM, Xu YZ, Liu HF. IgA nephropathy patients with partial crescent formation benefit from immunosuppressants: evidence from repeat renal biopsy. Discov Med. 2020;30(159):19\u201325.","journal-title":"Discov Med"},{"issue":"8","key":"5101_CR18","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s00467-024-06361-1","volume":"39","author":"B Su","year":"2024","unstructured":"Su B, Jiang Y, Li Z, Zhou J, Rong L, Feng S, et al. Are children with IgA nephropathy different from adult patients? Pediatr Nephrol. 2024;39(8):2403\u201312. https:\/\/doi.org\/10.1007\/s00467-024-06361-1.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"5101_CR19","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/ki.2014.63","volume":"86","author":"R Coppo","year":"2014","unstructured":"Coppo R, Troyanov S, Bellur S, Cattran D, Cook HT, Feehally J, et al. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int. 2014;86(4):828\u201336. https:\/\/doi.org\/10.1038\/ki.2014.63.","journal-title":"Kidney Int"},{"issue":"10","key":"5101_CR20","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/ki.2010.43","volume":"77","author":"R Coppo","year":"2010","unstructured":"Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Coppo R, Troyanov S, Camilla R, Hogg RJ, Cattran DC, et al. The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int. 2010;77(10):921\u201327. https:\/\/doi.org\/10.1038\/ki.2010.43.","journal-title":"Kidney Int"},{"issue":"3","key":"5101_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00467-016-3502-6","volume":"32","author":"Y Shima","year":"2017","unstructured":"Shima Y, Nakanishi K, Sato M, Hama T, Mukaiyama H, Togawa H, et al. IgA nephropathy with presentation of nephrotic syndrome at onset in children. Pediatr Nephrol. 2017;32(3):457\u201365. https:\/\/doi.org\/10.1007\/s00467-016-3502-6.","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"5101_CR22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s40620-016-0360-z","volume":"30","author":"R Coppo","year":"2017","unstructured":"Coppo R. Clinical and histological risk factors for progression of IgA nephropathy: an update in children, young and adult patients. J Nephrol. 2017;30(3):339\u201346. https:\/\/doi.org\/10.1007\/s40620-016-0360-z.","journal-title":"J Nephrol"},{"issue":"11","key":"5101_CR23","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.2169\/internalmedicine.43.1023","volume":"43","author":"H Komatsu","year":"2004","unstructured":"Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Eto T. Relationship between serum IgA\/C3 ratio and progression of IgA nephropathy. Intern Med. 2004;43(11):1023\u201328. https:\/\/doi.org\/10.2169\/internalmedicine.43.1023.","journal-title":"Intern Med"},{"issue":"8","key":"5101_CR24","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.34067\/KID.0000000000000195","volume":"4","author":"AJ Howie","year":"2023","unstructured":"Howie AJ, Lalayiannis AD. Systematic review of the Oxford classification of IgA nephropathy: reproducibility and prognostic value. Kidney360. 2023;4(8):1103\u201311. https:\/\/doi.org\/10.34067\/KID.0000000000000195.","journal-title":"Kidney360"},{"key":"5101_CR25","doi-asserted-by":"publisher","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;100(4):S1\u2013S276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021.","DOI":"10.1016\/j.kint.2021.05.021"},{"key":"5101_CR26","doi-asserted-by":"publisher","unstructured":"Melkonian AL, Cheung MD, Erman EN, Moore KH, Lever JMP, Jiang Y, et al. Single-cell RNA sequencing and spatial transcriptomics reveal unique subpopulations of infiltrating macrophages and dendritic cells following AKI. Am J Physiol-Renal Physiol. 2025;328(6):F907\u201320. https:\/\/doi.org\/10.1152\/ajprenal.00059.2025.","DOI":"10.1152\/ajprenal.00059.2025"},{"issue":"1","key":"5101_CR27","doi-asserted-by":"publisher","first-page":"7567","DOI":"10.1038\/s41467-025-62599-9","volume":"16","author":"Q Xuanyuan","year":"2025","unstructured":"Xuanyuan Q, Wu H, Sundaramoorthi H, Isnard P, Chen C, Rahmani W, et al. Multimodal spatial transcriptomic characterization of mouse kidney injury and repair. Nat Commun. 2025;16(1):7567. https:\/\/doi.org\/10.1038\/s41467-025-62599-9. 2025 Aug 14.","journal-title":"Nat Commun"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05101-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05101-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05101-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:11:11Z","timestamp":1781676671000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05101-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5101"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05101-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Wuhan Children\u2019s Hospital (Approval No: 2025R091-E01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of retrospective study using anonymous registry data, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"372"}}